Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Clinical trial NCT03745326 · TERMINATED
Trial details
- NCT number
- NCT03745326
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2022-08-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.